Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

We have observed 6 EP applications Fatema Elyasali Sardharwala has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12716003

TETRAHYDROPYRAZOLO [1,5 -A]PYRIMIDINE AS ANTI -TUBERCULOSIS COMPOUNDS

IPC classification:
A61K 31/4162, C07D 487/04
Applicant:
Glaxo Group Limited
Agent:
Fatema Elyasali Sardharwala, GlaxoSmithKline
Agent:
GlaxoSmithKline Intellectual Property Limited
Agent:
Fatema Elyasali Sardharwala, GlaxoSmithKline Intellectual Property Development Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15196303

BIPHENYL DERIVATIVE AND ITS USE FOR TREATING PULMONARY DISORDERS

IPC classification:
A61K 31/4709, A61P 11/00, A61P 11/06, C07D 401/12
Agent:
Fatema Elyasali Sardharwala, GlaxoSmithKline
Status:
PATENT GRANTED
EP11771075

3-AMINO-PYRAZOLE DERIVATIVES USEFUL AGAINST TUBERCULOSIS

IPC classification:
A61K 31/425, A61K 31/427, A61P 31/06, C07D 417/14
Applicant:
Glaxo Group Limited
Agent:
Fatema Elyasali Sardharwala, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16204387

BENZIMIDAZOLE DERIVATIVES AS PI3 KINASE INHIBITORS

IPC classification:
A61K 31/4184, A61P 35/00, C07D 235/08, C07D 235/10, C07D 235/24, C07D 401/06, C07D 403/04, C07D 405/04, C07D 409/06, C07D 413/04, C07D 417/04
Applicant:
GlaxoSmithKline LLC
Agent:
Fatema Elyasali Sardharwala, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15817827

THIOTRIAZOLE COMPOUND AND ITS USE IN PARASITIC PROTOZOAL INFECTIONS

IPC classification:
A61K 31/44, A61P 33/06, C07D 401/14
Agent:
Fatema Elyasali Sardharwala, GlaxoSmithKline
Status:
Request for examination was made
EP16701304

PYRAZOLO[3,4-D]PYRIMIDIN DERIVATIVE AND ITS USE FOR THE TREATMENT OF LEISHMANIASIS

IPC classification:
A61K 31/519, A61P 33/00, C07D 487/04
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Applicant:
University of Dundee
Agent:
Fatema Elyasali Sardharwala, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature